From Yahoo Finance: 2025-05-14 11:00:00

Polen Capital released its Q1 2025 investor letter, showing a shift from optimism to fear due to Trump election fallout. The fund delivered -10.53% gross and -10.83% net of fees, compared to the Russell 2000 Growth Index’s -11.12% return. Bio-Techne Corporation (NASDAQ: TECH) was highlighted with a market cap of $7.722 billion.

In Q1 2025, Polen U.S. Small Company Growth Strategy discussed Bio-Techne Corporation (NASDAQ: TECH) in its investor letter. The company develops life science reagents, instruments, and services, with a one-month return of -1.41%. Its stock closed at $51.61 per share on May 13, 2025. Polen Capital initiated a new position in Bio-Techne Corporation (NASDAQ: TECH).

Bio-Techne Corporation (NASDAQ: TECH) saw 24 hedge fund portfolios holding its stock at the end of Q4, down from 25 in Q3. The company generated $316.2 million in revenues in Q2 of fiscal 2025, up 6% year-over-year. While Bio-Techne Corporation (NASDAQ: TECH) shows potential, Polen Capital believes AI stocks offer greater returns. Check out their report for the cheapest AI stock option.

Read more: What Makes Bio-Techne Corporation (TECH) a Compelling Addition?